International Companies

Germany's Merck to buy Bio-Techne for $11.3bn

By Michele Maatouk

Date: Thursday 25 Jun 2026

(Sharecast News) - Germany's Merck KGaA said on Thursday that it has agreed to buy Minneapolis-based biotech company Bio-Techne for around $11.3bn.
Under the terms of the deal, Merck will pay $73 per share in cash, which is a 24% premium to Bio-Techne's closing share price on Wednesday.

Bio-Techne is...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page